Real-world effectiveness of prophylactic tixagevimab-cilgavimab monoclonal antibodies on incidence and severity of COVID-19 infection in patients with cancer.
Year: 2023
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: University of Massachusetts Chan Medical School
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4379280977
